NEWS & EVENTS
News: Variantyx Surpasses 2,500 Genomes Analyzed, Highlights the Value of Its WGS-Based Testing Methodology
Clinicians at Variantyx, a leader in high complexity hereditary disease testing, recently completed analysis of their 2,500th patient genome. The milestone highlights the growing need for whole genome sequencing (WGS)-based tests in patient genetic diagnostics …
Article: Helping Clinicians Solve Genetic Puzzles
In 2003, an international consortium of health institutes and government agencies completed “The Human Genome Project.” The scientific world considered the effort to sequence the three billion DNA letters in the human genome as one of the most ambitious of all time …
News: Variantyx Licenses IBM Technologies That Leverage AI for Somatic Analysis
Variantyx today announced that it has entered into a licensing agreement with IBM for technologies that leverage artificial intelligence for somatic analysis …